autism | CARLAT PUBLISHING

Treating Irritability in Autistic Children: Functional and Medication Approaches

April 24, 2023

Antipsychotics can be very effective for irritability in autism, but they are often unnecessary, and the side effects are truly problematic. Don’t be the prescriber who hears irritability in autism and immediately prescribes antipsychotics. There are usually multiple steps to try before using the FDA-approved antipsychotic medications.

Research Update

Autistic Drivers Perform Well

April 1, 2023

Jason Emejuru, MD

Jason Emejuru, MD. Dr. Emejuru has no financial relationships with companies related to this material.

Driving is a critical skill for many autistic people we see. But do autistic drivers have more accidents? How are their accidents different from those of non-autistic drivers? This research update gives you insight that you can use to help the autistic drivers you see to better prepare for safer driving.

Expert Q&A

Recognizing and Treating Psychosis in Autism

April 1, 2023

Kristin Cadenhead, MD

Kristin Cadenhead, MD.

Professor of psychiatry. Director, Cognitive Assessment and Risk Evaluation (CARE) Early Psychosis Treatment and Research Program, University of California, San Diego.

Dr. Cadenhead has no financial relationships with companies related to this material.

Is it autism or psychosis or both? Autistic traits and psychotic symptoms can look a lot alike. How common is psychosis in autism? And how can we differentiate co-occurring autistic traits from psychotic symptoms? Dr. Kristin Cadenhead gives us an approach for sorting through the history and addressing these problems separately.

Clinical Update

Treating Irritability in Autism: Functional and Medication Approaches

April 1, 2023

Joshua Feder, MD

Joshua D. Feder, MD. Editor-in-Chief, The Carlat Child Psychiatry Report.

Dr. Feder has no financial relationships with companies related to this material.

Antipsychotics can be very effective for irritability in autism, but they are often unnecessary, and the side effects are truly problematic. Don’t be the prescriber who hears irritability in autism and immediate prescribes antipsychotics. There are usually multiple steps to try before using the FDA approved antipsychotic medications.

Expert Q&A

Addressing Suicidality in Autistic Children and Teens

April 1, 2023

Paul Lipkin, MD

Paul Lipkin, MD.

Neurodevelopmental and developmental behavioral pediatrician. Director, Medical Outpatient Services, Kennedy Krieger Institute, Baltimore, MD.

Dr. Lipkin has served as an advisor for EarliTec and Sarepta Diagnostics. Relevant financial relationships listed for the author have been mitigated.

Autistic kids and teens can become despondent or suicidal. When this happens, we need to take it as seriously as with anyone else. We interviewed Dr. Paul Lipkin who has truly useful tips to help us modify our assessment to communicate effectively back and forth to address the problem.

Addressing Sensory Processing Challenges

February 12, 2023

Joshua Feder, MD and Mara Goverman

Learn to identify sensory challenges to address these barriers to effective care in teens and adolescents.

Interpreting Assessment Discrepancies from Multiple Sources

October 17, 2022

Joshua Feder, MD and Mara Goverman

In this episode, we will discuss why assessment discrepancies arise, how we can manage them, and what these discrepancies tell us about a patient’s symptoms and response to treatment.

Approaches to Autism Intervention

May 20, 2021

Diane Cullinane, MD.

Diane Cullinane, MD. Developmental pediatrician. Co-founder and Executive Director Emerita of Professional Child Development Associates (PCDA), Pasadena, CA. Dr. Cullinane has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How to respond to the seismic shift in our understanding of effect sizes in autism treatment? With better informed consent: we supplemented our interview with Dr Sandbank with an article by Dr Diane Cullinane on the three main kinds of autism treatment so that you will be prepared to help families know that they have choices.

Effect Size Matters: The Seismic Shift Toward Naturalistic and Developmental Interventions in Autism

May 20, 2021

Micheal P Sandbank, PhD

Micheal P Sandbank, PhD

Assistant professor of special education at the University of Texas, Austin. Dr. Sandbank has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Thousands of studies that carry the weight of support for Applied Behavioral Analysis treatment for autism are flawed. See what we learned about effect sizes for this massive 17-billion-dollar industry and learn about why it is so hard to study more functional but meaningful change vs rote but less useful learning.

Pharmacotherapy for Autism Spectrum Disorder

May 20, 2021

Matthew Krause, DO

Matthew Krause, DO

Child psychiatrist with Primary Health Network, Latrobe, PA Dr. Krause has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What’s new in psychopharmacological treatment for autism? We interviewed Dr. Matthew Krause on his recent review of seven studies covering the rationale for treatment, target symptoms, the use of antipsychotics, over the counter supplements, and some new ideas in pharmacotherapy for ASD.